![](https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEgZy8_ugxrucQNPrB1YGfmEQp9f9wqacFWxQs3TzYqgNqSNFsKfCHDd3h0bAOq0jyUjHUJCu8bPg11KuipiqfsroDwgif9DCGZ_YOBuketViu7A9cbJIBTFPTdMC7Hm0nRgVw3Ew1kfFyE/s200/abracadabarcelona+-+water.jpg)
http://picasaweb.google.com/europeanbioanalysisforum/EBF1stOpenSymposiumBurningIssuesInBioanalysis
News and announcements of the European Bioanalysis Forum (EBF)
On 3 December FDA released their draft guideline on immunogenicity testing on their website:
Guidance for Industry: Assay Development for Immunogenicity Testing of Therapeutic Proteins
The consultation period is 60 days.
The EMEA draft
GUIDELINE ON VALIDATION OF BIOANALYTICAL METHODS
has been made available on the EMEA website.
For downloading this important document use:
http://www.emea.europa.eu/pdfs/human/ewp/19221709en.pdf
Deadline for comments: 31 May 2010